Mode
Text Size
Log in / Sign up

Cocaine and amphetamine use significantly increase stroke risk as confirmed by Mendelian randomizationDrug use linked to higher risk of stroke in large study

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize that cocaine and amphetamine use are significantly associated with increased stroke risk.

This systematic review and meta-analysis synthesizes evidence from 32 studies involving over 100 million participants to evaluate the relationship between various substances—including cannabis, cocaine, amphetamines, opioids, and nicotine—and stroke risk. The study utilizes both observational data and Mendelian randomization (MR) to assess potential causal links.

Key findings indicate that cocaine use is associated with an increased stroke risk (OR = 1.96; 95% CI = 1.27-3.01), and amphetamine use shows a significant association (OR = 2.22; 95% CI = 1.40-3.53). Cannabis use was also associated with increased stroke risk (OR = 1.37; 95% CI = 1.14-1.65). In contrast, no significant association was observed for opioid use.

Mendelian randomization analyses provided further evidence: genetically predicted cannabis use disorder was associated with any stroke (OR = 1.11) and large artery stroke (OR = 1.35). Cocaine dependence was associated with cardioembolic stroke (OR = 1.08) and intracerebral hemorrhage (OR = 1.38). Genetically predicted substance use disorder was associated with any stroke (OR = 1.33) and a high risk of intracerebral hemorrhage (OR = 7.79).

The authors noted some heterogeneity and small-study effects regarding cannabis findings. These results suggest significant public health implications for prevention strategies targeting substance use disorders to mitigate stroke risk.

How this fits prior evidence

This meta-analysis addresses a gap in understanding the causal link between substance use and stroke. While prior coverage has focused on post-stroke management, such as botulinum toxin for spasticity, Levodopa for motor recovery, HF-rTMS for cognitive impairment, NIVR for upper limb function, and dual antiplatelet therapy to reduce recurrence, this study provides evidence on primary risk factors. Specifically, it confirms that cocaine and amphetamines are associated with increased stroke risk using both observational and genetic data.

Stroke is a medical emergency that can cause lasting damage or even death. New research looking at data from more than 100 million people has identified specific risks linked to different types of drug use. The study looked at how substances like cannabis, cocaine, and amphetamines affect the likelihood of having a stroke.

The findings show a clear link between certain drugs and higher stroke risk. For example, users of cocaine and amphetamines showed significantly higher risks. Specifically, people with a genetic predisposition toward cocaine dependence were more likely to experience types of strokes involving large arteries or internal bleeding. While cannabis use was also linked to increased risk, the data for that specific substance was less consistent across different studies.

It is important to note that while these links are strong for cocaine and amphetamines, the study did not find a significant link between opioid use and stroke. Because every person's health history is unique, people concerned about how their habits affect their heart or brain health should talk to a doctor to create a personal prevention plan.

What this means for you:
Cocaine and amphetamine use are linked to significantly higher risks of stroke compared to other substances.

Common questions

Which drugs were linked to a higher risk of stroke?

The study found that both cocaine and amphetamines were significantly associated with an increased risk of stroke. Specifically, the data showed a 1.96 times higher risk for cocaine use and a 2.22 times higher risk for amphetamine use compared to those who did not use them.

Was there a link between opioid use and stroke?

No, the study did not find a significant association between opioid use and the risk of having a stroke. While other drugs showed clear links, the data for opioids did not show a statistically significant increase in stroke risk.

What were the findings regarding cannabis use?

Cannabis use was associated with an increased risk of stroke. However, researchers noted that these specific findings showed some variation and small-study effects, meaning the data for cannabis was less consistent than the results found for cocaine or amphetamines.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
BACKGROUND: Epidemiological evidence suggests associations between substance use disorders and risk of stroke, but whether these are due to confounding or are true causal relationships remains uncertain. AIMS: To meta-analyze the observational evidence on illicit substance use and stroke risk and apply Mendelian randomization (MR) to evaluate potential causal effects of substance dependence on stroke subtypes. METHODS: We conducted a systematic review and meta-analysis of studies reporting associations between illicit drug use and stroke (PROSPERO registration-CRD420251053702). The meta-analysis included 32 studies comprising more than 100 million total participants across administrative, hospital-based, and population-based datasets. Pooled odds ratios (ORs) were estimated using multivariate random-effects models for ischemic and hemorrhagic subtypes. We then performed two-sample MR using genome-wide association study summary statistics to examine associations between seven drug exposures and all stroke, ischemic and hemorrhagic stroke, and ischemic stroke subtypes. RESULTS: Meta-analysis demonstrated significant associations of cannabis (OR = 1.37, 95% confidence interval (95% CI) = 1.14-1.65), cocaine (OR = 1.96; 95% CI = 1.27-3.01), and amphetamines (OR = 2.22, 95% CI = 1.40-3.53) with increased stroke risk, while no significant association was observed for opioids. Findings for cannabis showed some heterogeneity and small-study effects. MR analyses revealed that cannabis use disorder was associated with any stroke (OR = 1.11 [1.01-1.51]) and large artery stroke (OR = 1.35, 95% CI = 1.01-1.80), and cocaine dependence was associated with cardioembolic stroke (OR = 1.08, 95% CI = 1.02-1.14) and intracerebral hemorrhage (OR = 1.38, 95% CI = 1.15-1.65). Genetically predicted substance use disorder overall was associated with any stroke (OR = 1.33, 95% CI = 1.02-1.72) and intracerebral hemorrhage (OR = 7.79, 95% CI = 3.46-17.54). Problematic and dependent alcohol use was linked to large artery and cardioembolic stroke, whereas nicotine dependence showed no significant associations. CONCLUSION: Our findings provide consistent observational and genetic evidence that several forms of substance misuse increase stroke risk, particularly cocaine, amphetamines, and cannabis. These findings suggest important public health implications for prevention strategies targeting substance use disorders to mitigate stroke risk.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.